These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3179437)

  • 21. Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4-one iron chelators in overloaded and nonoverloaded mice.
    Porter JB; Hoyes KP; Abeysinghe RD; Brooks PN; Huehns ER; Hider RC
    Blood; 1991 Nov; 78(10):2727-34. PubMed ID: 1824264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of a novel oral iron chelator: 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-one.
    Pangjit K; Banjerdpongchai R; Phisalaphong C; Fucharoen S; Xie YY; Lu ZD; Hider RC; Srichairatanakool S
    J Pharm Pharmacol; 2015 May; 67(5):703-13. PubMed ID: 25627251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating site.
    Porter JB; Abeysinghe RD; Hoyes KP; Barra C; Huehns ER; Brooks PN; Blackwell MP; Araneta M; Brittenham G; Singh S
    Br J Haematol; 1993 Sep; 85(1):159-68. PubMed ID: 8251385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and evaluation of N-basic substituted 3-hydroxypyridin-4-ones: orally active iron chelators with lysosomotrophic potential.
    Liu ZD; Khodr HH; Lu SL; Hider RC
    J Pharm Pharmacol; 2000 Mar; 52(3):263-72. PubMed ID: 10757413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chelation and mobilization of cellular iron by different classes of chelators.
    Zanninelli G; Glickstein H; Breuer W; Milgram P; Brissot P; Hider RC; Konijn AM; Libman J; Shanzer A; Cabantchik ZI
    Mol Pharmacol; 1997 May; 51(5):842-52. PubMed ID: 9145923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II).
    Breuer W; Epsztejn S; Cabantchik ZI
    J Biol Chem; 1995 Oct; 270(41):24209-15. PubMed ID: 7592626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular pharmacology of deferrioxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilization.
    Laub R; Schneider YJ; Octave JN; Trouet A; Crichton RR
    Biochem Pharmacol; 1985 Apr; 34(8):1175-83. PubMed ID: 3994740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
    J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria.
    Hershko C; Gordeuk VR; Thuma PE; Theanacho EN; Spira DT; Hider RC; Peto TE; Brittenham GM
    J Inorg Biochem; 1992 Aug 15-Sep; 47(3-4):267-77. PubMed ID: 1431886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, physicochemical properties, and evaluation of novel iron chelators with fluorescent sensors.
    Ma Y; Luo W; Quinn PJ; Liu Z; Hider RC
    J Med Chem; 2004 Dec; 47(25):6349-62. PubMed ID: 15566304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
    Dobbin PS; Hider RC; Hall AD; Taylor PD; Sarpong P; Porter JB; Xiao G; van der Helm D
    J Med Chem; 1993 Aug; 36(17):2448-58. PubMed ID: 8355246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, physicochemical characterization, and biological evaluation of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe(3+) values.
    Liu ZD; Khodr HH; Liu DY; Lu SL; Hider RC
    J Med Chem; 1999 Nov; 42(23):4814-23. PubMed ID: 10579844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron mobilisation and cellular protection by a new synthetic chelator O-Trensox.
    Rakba N; Aouad F; Henry C; Caris C; Morel I; Baret P; Pierre JL; Brissot P; Ward RJ; Lescoat G; Crichton RR
    Biochem Pharmacol; 1998 Jun; 55(11):1797-806. PubMed ID: 9714298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
    Devanur LD; Evans RW; Evans PJ; Hider RC
    Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of iron from ferritin molecules and their iron-cores by 3-hydroxypyridinone chelators in vitro.
    Brady MC; Lilley KS; Treffry A; Harrison PM; Hider RC; Taylor PD
    J Inorg Biochem; 1989 Jan; 35(1):9-22. PubMed ID: 2709002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The environment of the lipoxygenase iron binding site explored with novel hydroxypyridinone iron chelators.
    Abeysinghe RD; Roberts PJ; Cooper CE; MacLean KH; Hider RC; Porter JB
    J Biol Chem; 1996 Apr; 271(14):7965-72. PubMed ID: 8626476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators.
    Liu ZD; Kayyali R; Hider RC; Porter JB; Theobald AE
    J Med Chem; 2002 Jan; 45(3):631-9. PubMed ID: 11806714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools.
    Hoyes KP; Porter JB
    Br J Haematol; 1993 Oct; 85(2):393-400. PubMed ID: 8280612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK.
    Petrat F; Rauen U; de Groot H
    Hepatology; 1999 Apr; 29(4):1171-9. PubMed ID: 10094962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice.
    Eybl V; Caisová D; Koutenský J; Kontoghiorghes GJ
    Arch Toxicol Suppl; 1991; 14():185-7. PubMed ID: 1805729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.